Evidence map›Paper›PMID 42486854›Full record

ArticleCell death & disease2026

Loss of Atp8a2 drives neurodegeneration through the dysregulation of spatiotemporal phosphatidylserine externalization in mature neurons.

Adriana Schneider, Alexandra B Merkel, Nunzio Perta, Lisa Ruff, Netta Ussyshkin, Paula Zimmer, Bahar Aksan, Amandine Lepeuve, Laura D'Andrea, Silvia Pelucchi and 3 more

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Adriana SchneiderDepartment of Neurobiology, Interdisciplinary Centre for Neurosciences (IZN), Heidelberg University, Heidelberg, Germany.ORCID http://orcid.org/0009-0009-5250-2591
Alexandra B MerkelDepartment of Neurobiology, Interdisciplinary Centre for Neurosciences (IZN), Heidelberg University, Heidelberg, Germany.
Nunzio PertaDepartment of Life and Environmental Sciences, Marche Polytechnic University, Ancona, Italy.ORCID http://orcid.org/0000-0003-2558-8413
Lisa RuffDepartment of Neurobiology, Interdisciplinary Centre for Neurosciences (IZN), Heidelberg University, Heidelberg, Germany.
Netta UssyshkinDepartment of Neurobiology, Interdisciplinary Centre for Neurosciences (IZN), Heidelberg University, Heidelberg, Germany.
Paula ZimmerDepartment of Neurobiology, Interdisciplinary Centre for Neurosciences (IZN), Heidelberg University, Heidelberg, Germany.ORCID http://orcid.org/0009-0000-0345-9907
Bahar AksanDepartment of Neurobiology, Interdisciplinary Centre for Neurosciences (IZN), Heidelberg University, Heidelberg, Germany.
Amandine LepeuveDepartment of Neurobiology, Interdisciplinary Centre for Neurosciences (IZN), Heidelberg University, Heidelberg, Germany.
Laura D'AndreaDepartment of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Milan, Italy.ORCID http://orcid.org/0000-0002-2042-9782
Silvia PelucchiDepartment of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Milan, Italy.
Elena MarcelloDepartment of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Milan, Italy.ORCID http://orcid.org/0000-0003-0452-762X
Daniele Di MarinoDepartment of Life and Environmental Sciences, Marche Polytechnic University, Ancona, Italy.
Daniela MauceriDepartment of Neurobiology, Interdisciplinary Centre for Neurosciences (IZN), Heidelberg University, Heidelberg, Germany. mauceri@uni-marburg.de.ORCID http://orcid.org/0000-0003-1225-4633

Funding

Alzheimer Forschung Initiative (Alzheimer Forschung Initiative e.V.) 21019Deutsche Forschungsgemeinschaft (German Research Foundation) MA 5951/2-1Deutsche Forschungsgemeinschaft (German Research Foundation) SFB1158 A08Giovanni Armenise-Harvard Foundation 2023 Armenise Harvard-AIRALZH Mid-Career Award in Neurodegenerative Diseases - AHA MCAJoachim Herz Stiftung (Joachim Herz Foundation) Add-On FellowshipMinistero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) PRIN2022 PNRR P2022R2E8N
6 · The paper itself

Abstract

Phosphatidylserine (PS) asymmetry in plasma membranes is critical for cellular functions and serves as an apoptotic signal in many cell types. However, in mature neurons, the molecular mechanisms governing PS distribution, its precise regulation, and its functional significance beyond apoptosis and development remain poorly understood - particularly in the context of neurodegeneration. Here, we mapped the spatiotemporal dynamics of PS exposure in mature hippocampal neurons under physiological and pathological conditions using time-lapse imaging, revealing specific PS externalization hotspots at dendritic branching points. Using multiple in vitro and in vivo neurodegeneration models combined with molecular modeling, RNA interference, pharmacological interventions, and biochemical assays, we identified Atp8a2 as the primary regulator of PS asymmetry in mature neurons beyond its known roles in development. Notably, Atp8a2 expression levels - rather than its flippase activity alone - were essential for maintaining neuronal structural integrity and viability. Atp8a2 expression was significantly altered by neurotoxic stimuli and in multiple mouse models of neurodegeneration. Reduced Atp8a2 expression led to increased PS exposure, compromised neuronal architecture, and heightened susceptibility to degeneration, whereas Atp8a2 overexpression conferred substantial neuroprotection. The distinction between Atp8a2's enzymatic activity and expression level reveals a mechanism of neuronal homeostasis linking PS regulation to structural integrity and survival, possibly through association with cytoskeletal protein networks. Thus, Atp8a2 expression is a critical determinant of mature neuronal viability, presenting a potential target for neuroprotective strategies in neurodegeneration.

Indexed as

Nerve DegenerationNeurodegenerative DiseasesNeuronsPhosphatidylserinesPhospholipid Transfer ProteinsAnimalsApoptosisHippocampusHumansMicePhosphatidylserinesPhospholipid Transfer Proteins

Identifiers

PMID42486854
PMCPMC13392023

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.